Helsingin ja Uudenmaan Sairaanhoitopiiri; Suomen Akatemia; Päivikki ja Sakari Sohlbergin Säätiö; Paulo Foundation Problem: The accuracy of Chlamydia trachomatis antibody test in predicting tubal factor infertility (TFI) is limited, and more accurate methods are needed. Cell-mediated immune response (CMI) is crucial in the resolution of pathogen, but it may play an important role in the pathogenesis of C trachomatis-associated tubal damage. We studied whether combining the markers of C trachomatis-induced CMI to humoral immune response improves the accuracy of serology in TFI prediction.
| INTRODUC TI ON
Chlamydia trachomatis infection is the most prevalent bacterial sexually transmitted disease with over 130 million cases detected annually worldwide. 1 Up to 80% of infections are asymptomatic and may therefore remain undiagnosed. If the infection is not resolved, C trachomatis can ascend to the upper genital tract and cause pelvic inflammatory disease (PID) which increases the risk of tubal factor infertility (TFI). 2 Laparoscopy has remained the gold standard for the diagnosis of TFI. However, it is costly, invasive and can potentially cause complications. Hysterosalpingography (HSG) and hysterosalpingosonography (HSSG) are less risky procedures for TFI diagnosis, but false-positive results are common. 3, 4 HSG and HSSG are also highly observer-dependent, and peritubal adhesions are not visualized by these procedures. In addition, these methods do not reveal impaired tubal function. In a recent meta-analysis, the sensitivity and specificity were 95% (78%-99%) and 93% (89%-96%) for HSSG, and 94%
(74%-99%) and 92% (87%-95%) for HSG compared to laparoscopy.
3
Numerous studies have shown that positive C. trachomatis serology is associated with tubal damage. 5, 6 Therefore, C. trachomatis
IgG antibody testing (CAT) has been used in infertility work-up to screen subfertile women with the highest risk of tubal pathology.
7,8
However, the accuracy of these tests is limited. The main limitations are the high rate of false-positive results and low positive predictive value (PPV). 9, 10 More accurate, non-invasive methods are needed for TFI diagnostics.
In chronic C. trachomatis infection, the expression of chlamydial heat-shock protein 60 (cHSP60) is highly upregulated. Several studies have shown that immune responses to cHSP60 are associated with PID, tubal occlusion and ectopic pregnancy (EP).
11,12
Furthermore, the presence of serum antibodies against cHSP60 may also predict TFI.
13,14
The clearance of C. trachomatis is known to depend on cell-mediated immune response (CMI). 15 However, in addition to the protective function, CMI is also associated with inflammatory pathological processes resulting in tubal damage. [16] [17] [18] The role of CMI in predicting TFI has been examined in our earlier studies, in which in vitro lymphocyte response against C trachomatis was more often detected in women with TFI than in healthy controls. 14, 18 As a result, we hypothesized that TFI prediction model could be further improved by adding markers of CMI to serology.
The aim of our study was to evaluate if combining markers of cell-mediated and humoral immune response against C. trachomatis improves the accuracy of serology in the prediction of TFI in clinical practice.
| MATERIAL S AND ME THODS

| Study population
Our study population consisted of 258 subfertile women referred for infertility investigations to Helsinki University Hospital during 
| Serological analysis and lymphocyte proliferation assay
Blood samples for immunological analysis were collected at the first serovar E and F, total protein concentration 3 µg/mL) and recombinant CHSP60 (2.5 µg/mL) were used as lymphocyte-stimulating antigens. 15 The results were expressed as stimulation indices (SI, or mean count per minute in the presence of antigen, divided by mean count per minute in its absence) for triplicate cultures. SI > 5 was considered a positive response to chlamydial EB antigen, and SI > 2.5
was considered a positive response to cHSP60 antigen.
| Statistical analysis
Chi-squared test was used for the analysis of categorical data. The flow chart of the study population is presented in Figure 1 .
| RE SULTS
| TFI in the study population
The baseline characteristics of the study population are shown in Table 1 . Women with TFI were older than women with other causes of subfertility (mean 33.1 vs 31.2 years, P = 0.04) and were more likely to have secondary infertility (54.5% vs 27.1%, P = 0.007).
Smoking was associated with TFI (38.1% vs 16.0%, P = 0.03).
Altogether, 37 (14.3%) of the 258 women reported prior history of chlamydial infection and six (2.3%) reported recurrent (two or more episodes) infection. Three women (1.2%) reported a history of PID.
None of the participants had a positive C. trachomatis NAAT from urogenital sample at the time of infertility evaluation. During the follow-up, the live birth rate was significantly lower in the TFI group than in the non-TFI group (58.8% vs 89.8%, P < 0.001).
| Immune response to C. trachomatis
The prevalence of C. trachomatis-induced humoral and cell-mediated immunological markers in the study population is shown in Table 2 . All serological markers were more often positive in TFI cases than in cases with other causes for subfertility. Table 3 shows the performance of immunological tests and test combina- antibody and EB lymphocyte proliferation test was used, the PPV increased to 40.0% (Table 3) . Positive and negative post-test probabilities are shown in Table 3 . Positive post-test probability of the combination of MOMP and cHSP60 antibody was 54.2%, and 54.4% when EB proliferation test was combined with the serological combination. LR+and LR-of MOMP and cHSP60 antibody combination were 6.7 and 0.8, respectively. Adding cHSP60 lymphocyte proliferation test to serological tests did not increase the performance of the tests.
| D ISCUSS I ON
The aim of our study was to evaluate whether C. trachomatis serology for TFI prediction can be improved by combining tests of C. trachomatis-specific humoral and cell-mediated immune response. We found that the accuracy of TFI prediction increases when the combination of C. trachomatis MOMP and cHSP60 antibody tests is used.
Adding the markers of CMI to the antibody tests did not significantly
improve the accuracy of TFI prediction.
Of the single tests, cHSP60 IgG had the highest specificity for predicting TFI in our study, but the sensitivity of the test was low indicating a high number of cHSP60-negative cases among women with TFI C. trachomatis MOMP IgG test yielded better sensitivity, but as shown in previous studies , 6,10 it had relatively low specificity TA B L E 2 The prevalence (%) of positive immunological tests against Chlamydia trachomatis and cHSP60 in TFI cases and in women with other causes for subfertility
TFI (N = 22) Non-TFI (N = 236) P-value
Humoral immune markers (%, n) Post-test probability was calculated with pre-test probability value 15% for TFI. EB, elementary body; LP, lymphocyte proliferation.
in predicting TFI although this is a species-specific test for detecting serum C trachomatis antibodies. 9 This is likely to result from a high number of sero-positive cases among women with non-TFI subfertility.
We found that the specificity of C trachomatis serology can be improved by using the combination of MOMP and cHSP60 antibody.
This combination had highest accuracy (90.3%) and PPV of 38.5%
in our study population in which TFI prevalence was 8.5%. While PPV depends on the prevalence of the disease, the predictive value of the test combination would be higher in a population with higher TFI prevalence. With an estimated pre-test TFI prevalence of 15%, this antibody combination indicates a 54.2% risk of C trachomatis-induced TFI after a positive test result.
When evaluating the performance of a clinical test, LR is considered more useful measure than sensitivity and specificity. In our study, tubal evaluation was mainly performed by HSSG which is known to have limited accuracy and low inter-observer reproducibility. 3 Moreover, peritubal adhesions or minor tubal damage (ie, destruction of functional tubal epithelium and loss of cilia) cannot be revealed by this procedure. These milder forms of TFI may lead to impaired function of fimbriae or fallopian tubes. In our study, women with EP were included in the TFI group, since EP suggests tubal disease.
Chlamydia trachomatis-associated proportion of all TFI is estimated to be between 29% to 45%, and repeat episodes of chlamydial infection increase the risk of tubal damage. 24 However, the pathogenesis of TFI is multifactorial. Not all TFI is attributed to prior C. trachomatis infection which reduces the performance of C. trachomatis-specific immunological tests in the prediction of TFI.
Our finding of lower live birth rate in TFI patients than in patients with other causes of subfertility is consistent with previous studies. 25, 26 It is well established that women with untreated hydrosalpinges are at higher risk of implantation failure and miscarriage. 27, 28 In our study population, two women had untreated hydrosalpinges. It is also possible that women with post-infectious TFI have chronic endometrial inflammation resulting in impaired implantation.
29,30
To the best of our knowledge, this is the first study evaluating the combinations of C trachomatis-induced humoral and cell-mediated immune responses in predicting TFI in clinical setting. C trachomatis-specific immune responses in the TFI cases were comparable to those in our earlier studies. 14, 18 However, the study design and the study population were different. In the present study, immune responses against C. trachomatis were measured in an unselected subfertile population, whereas in previous studies immune responses were compared between TFI cases and healthy controls.
Furthermore, the TFI cases in the previous studies had more severe forms of tubal damage, while in this study population only five women had bilateral tubal damage. In our study population, C. trachomatis-specific immune responses were common also in women with other causes for subfertility than TFI.
| CON CLUS IONS
In conclusion, the value of serology in evaluating C. trachomatis-as- 
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